Ryan Specialty Holdings, Inc. (NYSE:RYAN) EVP Brendan Martin Mulshine Sells 30,000 Shares

Ryan Specialty Holdings, Inc. (NYSE:RYAN) EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Ryan Specialty Stock Performance

Shares of NYSE:RYAN opened at $71.33 on Tuesday. The firm has a market capitalization of $18.68 billion, a PE ratio of 103.38, a P/E/G ratio of 1.19 and a beta of 0.71. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The business has a 50-day moving average of $67.30 and a two-hundred day moving average of $67.81. Ryan Specialty Holdings, Inc. has a 12 month low of $48.48 and a 12 month high of $75.97.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. As a group, research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.67%. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s dividend payout ratio is currently 69.57%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC boosted its holdings in Ryan Specialty by 3.7% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 11,755 shares of the company’s stock valued at $754,000 after purchasing an additional 420 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Ryan Specialty by 14.1% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 299,156 shares of the company’s stock valued at $19,194,000 after purchasing an additional 36,990 shares during the last quarter. Voloridge Investment Management LLC boosted its holdings in Ryan Specialty by 4.7% in the fourth quarter. Voloridge Investment Management LLC now owns 609,995 shares of the company’s stock valued at $39,137,000 after purchasing an additional 27,657 shares during the last quarter. Sone Capital Management LLC bought a new position in Ryan Specialty during the 4th quarter worth approximately $8,303,000. Finally, Waters Parkerson & CO. LLC lifted its holdings in Ryan Specialty by 9.9% during the 4th quarter. Waters Parkerson & CO. LLC now owns 358,710 shares of the company’s stock worth $23,015,000 after buying an additional 32,380 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on RYAN shares. UBS Group upped their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Morgan Stanley assumed coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price for the company. Wells Fargo & Company upped their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st. Barclays upped their target price on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Finally, Keefe, Bruyette & Woods dropped their target price on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Ryan Specialty presently has a consensus rating of “Hold” and an average price target of $75.27.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.